Invo Bioscience Inc Reports Results For The Quarter Ended In September: Earnings Summary

INVO Fertility

15/11/2021 23:45

* INVO Bioscience Inc  INVO.OQ  reported a quarterly adjusted
loss of 24 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 20 cents per share.
* Revenue was $218.00 thousand​;  analysts expected $325.50
thousand. 
* The mean earnings estimate of analysts had fallen by
about 48.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* INVO Bioscience Inc shares had risen by 1.2% this quarter and
gained 9.6% so far this year.
* Wall Street's median 12-month price target for INVO Bioscience
Inc is $5.63 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 11:45 p.m.
 ​All figures in US dollars unless otherwise stated